https://www.kymeratx.com/
Revolutionary Medicines Catalyzed by Protein Degradation | Kymera Therapeutics
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
revolutionary medicineskymera
https://investorshangout.com/kymera-therapeutics-plans-major-equity-offering-to-fund-pipeline-482594-/
Kymera Therapeutics Plans Major Equity Offering to Fund Pipeline - Investors Hangout
Kymera Therapeutics (NASDAQ: KYMR) is initiating a $500M public offering to advance its innovative drug pipeline for treating immunological diseases.
kymera therapeuticsplansmajor